News archive

Neupharma supports Mr. Pietro Armani's Association for patients with cystic fibrosis from Belarus, Ukraine and Kazakhstan

The new area of the website “DM PARI Service” is online and ready to be consulted

May 7, 2020: NEUPHARMA 2020 SITE IS ONLINE

Imola, November 2019: Neupharma is proud to have joined this important life-saving initiative for our community

Imola, 02 September 2019: Neupharma inaugurates the new corporate headquarters in the city centre of Imola.

On 19 June 2019, Neupharma Members collected the prestigious Industria Felix award. The ceremony was organized by the homonymous Cultural Association in collaboration with the CERVED Centre of Economic Studies, and it was held at the LUISS Guido Carli University of Rome.

Neupharma announces that it has acquired 15% of the PlumeStars Research Company. PlumeStars is based in Parma and is dedicated to the development of orphan products for rare diseases with a specific know-how in inhalation formulations.

The European Commission has granted the designation of orphan drug to Teicoplanin in inhalation formula for cystic fibrosis, a formula developed by Neupharma in collaboration with the non-profit company Rare Partners.